"......The trial will be conducted on 750 patients in a double blind placebo
controlled study randomized 1:1 of CVac vs. Standard of Care (currently
there is no approved maintenance therapy for ovarian cancer), across
multiple sites in
Europe, the US and
Australia....."
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.